Anne-Kathrin Stoller
Corporate Officer/Principal chez BACHEM HOLDING AG
Postes actifs de Anne-Kathrin Stoller
Sociétés | Poste | Début | Fin |
---|---|---|---|
BACHEM HOLDING AG | Corporate Officer/Principal | 01/03/2022 | - |
Sales & Marketing | 01/01/2018 | 01/03/2022 | |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Directeur/Membre du Conseil | 01/01/2006 | - |
Historique de carrière de Anne-Kathrin Stoller
Anciens postes connus de Anne-Kathrin Stoller
Sociétés | Poste | Début | Fin |
---|---|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Sales & Marketing | 01/01/2008 | 01/01/2010 |
Formation de Anne-Kathrin Stoller
University of Basel | Doctorate Degree |
Statistiques
Internationale
Suisse | 4 |
Opérationnelle
Sales & Marketing | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
BACHEM HOLDING AG | Health Technology |
Entreprise privées | 1 |
---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
- Bourse
- Insiders
- Anne-Kathrin Stoller
- Expérience